SCHEMBL606915

SCHEMBL606915

[N]=C1CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL605008 0.84
SCHEMBL1426215 0.80 TRIM24 (0.38)
SCHEMBL5961035 0.80
SCHEMBL1426651 0.80 TRIM24 (0.38)
SCHEMBL1425882 0.80 TRIM24 (0.38)
SCHEMBL1425898 0.80
SCHEMBL607128 0.80
SCHEMBL603869 0.76
SCHEMBL1495223 0.59
SCHEMBL7577171 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024110554-A1 N-[(1 -[2-[6-(PYRIDAZIN-3-YL]-1,2,4-TRIAZOL-3-YL]ETHYL]-QUINAZOLIN-4-AMINE AND N-[1-[3-(6-(PYRIDAZIN-3-YL)PYRAZIN-2-YL]ETHYL]-8-QUINAZOLIN-4-AMINE DERIVATIVES AS PESTICIDES SYNGENTA CROP PROTECTION AG (CH) 2024-05-30 WO claimed
WO-2024133551-A1 PESTICIDALLY ACTIVE PYRIDAZINE COMPOUNDS SYNGENTA CROP PROTECTION AG (CH) 2024-06-27 WO disclosed
WO-2024110554-A1 N-[(1 -[2-[6-(PYRIDAZIN-3-YL]-1,2,4-TRIAZOL-3-YL]ETHYL]-QUINAZOLIN-4-AMINE AND N-[1-[3-(6-(PYRIDAZIN-3-YL)PYRAZIN-2-YL]ETHYL]-8-QUINAZOLIN-4-AMINE DERIVATIVES AS PESTICIDES SYNGENTA CROP PROTECTION AG (CH) 2024-05-30 WO disclosed
US-11413274-B2 Methods and compositions associated with the granulocyte colony-stimulating factor receptor LIGAND PHARMACEUTICALS, INC. (US) 2022-08-16 US disclosed
US-20210046045-A1 METHODS AND COMPOSITIONS ASSOCIATED WITH THE GRANULOCYTE COLONY-STIMULATING FACTOR RECEPTOR CITIBANK, N.A., AS ADMINISTRATIVE AGENT 2021-02-18 US disclosed
US-10736875-B2 Methods and compositions associated with the granulocyte colony-stimulating factor receptor LIGAND PHARMACEUTICALS, INC. (US) 2020-08-11 US disclosed
US-10420748-B2 Methods of treatment associated with the granulocyte colony-stimulating factor receptor LIGAND PHARMACEUTICALS INCORPORATED (US) 2019-09-24 US disclosed
EP-2488486-B1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES LIGAND PHARM INC (US) 2019-08-14 EP disclosed
US-20180369197-A1 METHODS AND COMPOSITIONS ASSOCIATED WITH THE GRANULOCYTE COLONY-STIMULATING FACTOR RECEPTOR CITIBANK, N.A., AS ADMINISTRATIVE AGENT 2018-12-27 US disclosed
US-10111859-B2 Methods and compositions associated with the granulocyte colony-stimulating factor receptor LIGAND PHARMACEUTICALS, INC. (US) 2018-10-30 US disclosed
US-20120041193-A1 SUBSTITUTED INTERNAL VINYL-BORONIC ACIDS AND BORONIC ACID DERIVATIVES FRONTIER SCIENTIFIC, INC. (US) 2012-02-16 US disclosed
WO-2011046954-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES LIGAND PHARMACEUTICALS INC. (US) 2011-04-21 WO disclosed
US-RE39088-E1 Amide compounds and use of the same JAPAN TOBACCO, INC. (JP) 2006-05-02 US disclosed
WO-2005082459-A2 METHOD OF DECREASING BLOOD CELLS JAPAN TOBACCO INC. (JP) 2005-09-09 WO disclosed
US-20050187221-A1 Method of treating ischemia reperfusion injury JAPAN TOBACCO INC. (JP) 2005-08-25 US disclosed
EP-0849256-B1 AMIDE COMPOUNDS AND USE OF THE SAME JAPAN TOBACCO INC (JP) 2005-06-08 EP disclosed
EP-1304322-A2 Carboxylic acid compound and use thereof Japan Tobacco Inc. (JP) 2003-04-23 EP disclosed
US-6420561-B1 Amide compounds and use thereof JAPAN TOBACCO INC. (JP) 2002-07-16 US disclosed
US-6174887-B1 Amide compounds and use of the same JAPAN TOBACCO INC. (JP) 2001-01-16 US disclosed
EP-0849256-A1 AMIDE COMPOUNDS AND USE OF THE SAME Japan Tobacco Inc. (JP) 1998-06-24 EP disclosed